|
1
|
Pereira JO, Oliveira D, Faustino M, Vidigal SSMP, Pereira AM, Ferreira CMH, Oliveira AS, Durão J, Rodríguez-Alcalá LM, Pintado ME, Madureira AR, Carvalho AP. Use of Various Sugarcane Byproducts to Produce Lipid Extracts with Bioactive Properties: Physicochemical and Biological Characterization. Biomolecules 2024; 14:233. [PMID: 38397470 PMCID: PMC10886787 DOI: 10.3390/biom14020233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Revised: 01/31/2024] [Accepted: 02/06/2024] [Indexed: 02/25/2024] Open
Abstract
Sugarcane, a globally cultivated crop constituting nearly 80% of total sugar production, yields residues from harvesting and sugar production known for their renewable bioactive compounds with health-promoting properties. Despite previous studies, the intricate interplay of extracts from diverse sugarcane byproducts and their biological attributes remains underexplored. This study focused on extracting the lipid fraction from a blend of selected sugarcane byproducts (straw, bagasse, and filter cake) using ethanol. The resulting extract underwent comprehensive characterization, including physicochemical analysis (FT-IR, DSC, particle size distribution, and color) and chemical composition assessment (GC-MS). The biological properties were evaluated through antihypertensive (ACE), anticholesterolemic (HMG-CoA reductase), and antidiabetic (alpha-glucosidase and Dipeptidyl Peptidase-IV) assays, alongside in vitro biocompatibility assessments in Caco-2 and Hep G2 cells. The phytochemicals identified, such as β-sitosterol and 1-octacosanol, likely contribute to the extract's antidiabetic, anticholesterolemic, and antihypertensive potential, given their association with various beneficial bioactivities. The extract exhibited substantial antidiabetic effects, inhibiting α-glucosidase (5-60%) and DPP-IV activity (25-100%), anticholesterolemic potential with HMG-CoA reductase inhibition (11.4-63.2%), and antihypertensive properties through ACE inhibition (24.0-27.3%). These findings lay the groundwork for incorporating these ingredients into the development of food supplements or nutraceuticals, offering potential for preventing and managing metabolic syndrome-associated conditions.
Collapse
Affiliation(s)
- Joana Odila Pereira
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
- Amyris Bio Products Portugal Unipessoal Lda, 4169-005 Porto, Portugal
| | - Diana Oliveira
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
- Amyris Bio Products Portugal Unipessoal Lda, 4169-005 Porto, Portugal
| | - Margarida Faustino
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
| | - Susana S. M. P. Vidigal
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
| | - Ana Margarida Pereira
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
- Amyris Bio Products Portugal Unipessoal Lda, 4169-005 Porto, Portugal
| | - Carlos M. H. Ferreira
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
- Amyris Bio Products Portugal Unipessoal Lda, 4169-005 Porto, Portugal
| | - Ana Sofia Oliveira
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
| | - Joana Durão
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
- Amyris Bio Products Portugal Unipessoal Lda, 4169-005 Porto, Portugal
| | - Luís M. Rodríguez-Alcalá
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
| | - Manuela E. Pintado
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
| | - Ana Raquel Madureira
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
| | - Ana P. Carvalho
- CBQF—Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; (D.O.); (M.F.); (S.S.M.P.V.); (A.M.P.); (C.M.H.F.); (A.S.O.); (J.D.); (L.M.R.-A.); (M.E.P.); (A.R.M.); (A.P.C.)
| |
Collapse
|
|
2
|
Teixeira F, Costa PT, Vidigal SS, Pintado M, Pimentel LL, Rodríguez-Alcalá LM. Toward Sustainable Wax Extraction from the Saccharum officinarum L. Filter Cake Byproduct: Process Optimization, Physicochemical Characterization, and Antioxidant Performance. ACS SUSTAINABLE CHEMISTRY & ENGINEERING 2023; 11:13415-13428. [PMID: 37711765 PMCID: PMC10498761 DOI: 10.1021/acssuschemeng.3c03279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Revised: 08/16/2023] [Indexed: 09/16/2023]
Abstract
Saccharum officinarum L. exploitation and processing result in different byproducts, such as filter cake (FC). This study aimed to establish the most suitable experimental conditions to obtain lipophilic bioactive compounds from FC industrial residues, considering their high efficiency, cost-effectiveness, extraction yield, composition, and physicochemical properties. Results indicated that the most appropriate methodology consisted of the pretreatment of the FC sample with H2SO4, followed by ethanolic extraction (B6 method), avoiding energy-consumption FC drying steps and providing ethanol recovery (approx. 90%). The obtained B6 extract yield was 9.59 ± 0.27 g/100 g of FC dry weight, and this methodology proved to be more efficient in obtaining fatty alcohols (20.28 ± 1.48 g/kg extract) and phytosterols (31.56 ± 0.18 g/kg extract) while maintaining lower total monosaccharide concentration (26.19 ± 1.82 mg/g extract). Furthermore, the geographically related multivariate analysis in wax composition and antioxidant activity was evaluated by comparing B6 waxes from Guariba (G) and Univalem (U), both provided by Brazil and collected in June 2020. Overall, the wax composition is affected, but the antioxidant activity is uncompromised, which indicates that the optimized wax extraction method can be applied to FC.
Collapse
Affiliation(s)
- Francisca
S. Teixeira
- CBQF—Centro de Biotecnologia
e Química Fina—Laboratório Associado, Escola
Superior de Biotecnologia, Universidade
Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
| | - Paula T. Costa
- CBQF—Centro de Biotecnologia
e Química Fina—Laboratório Associado, Escola
Superior de Biotecnologia, Universidade
Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
| | - Susana S. Vidigal
- CBQF—Centro de Biotecnologia
e Química Fina—Laboratório Associado, Escola
Superior de Biotecnologia, Universidade
Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
| | - Manuela Pintado
- CBQF—Centro de Biotecnologia
e Química Fina—Laboratório Associado, Escola
Superior de Biotecnologia, Universidade
Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
| | - Lígia L. Pimentel
- CBQF—Centro de Biotecnologia
e Química Fina—Laboratório Associado, Escola
Superior de Biotecnologia, Universidade
Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
| | - Luís M. Rodríguez-Alcalá
- CBQF—Centro de Biotecnologia
e Química Fina—Laboratório Associado, Escola
Superior de Biotecnologia, Universidade
Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal
| |
Collapse
|
|
3
|
Differential Lipid Accumulation on HepG2 Cells Triggered by Palmitic and Linoleic Fatty Acids Exposure. Molecules 2023; 28:molecules28052367. [PMID: 36903612 PMCID: PMC10005272 DOI: 10.3390/molecules28052367] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 02/23/2023] [Accepted: 03/02/2023] [Indexed: 03/08/2023] Open
Abstract
Lipid metabolism pathways such as β-oxidation, lipolysis and, lipogenesis, are mainly associated with normal liver function. However, steatosis is a growing pathology caused by the accumulation of lipids in hepatic cells due to increased lipogenesis, dysregulated lipid metabolism, and/or reduced lipolysis. Accordingly, this investigation hypothesizes a selective in vitro accumulation of palmitic and linoleic fatty acids on hepatocytes. After assessing the metabolic inhibition, apoptotic effect, and reactive oxygen species (ROS) generation by linoleic (LA) and palmitic (PA) fatty acids, HepG2 cells were exposed to different ratios of LA and PA to study the lipid accumulation using the lipophilic dye Oil Red O. Lipidomic studies were also carried out after lipid isolation. Results revealed that LA was highly accumulated and induced ROS production when compared to PA. Lipid profile modifications were observed after LA:PA 1:1 (v/v) exposure, which led to a four-fold increase in triglycerides (TGs) (mainly in linoleic acid-containing species), as well as a increase in cholesterol and polyunsaturated fatty acids (PUFA) content when compared to the control cells. The present work highlights the importance of balancing both PA and LA fatty acids concentrations in HepG2 cells to maintain normal levels of free fatty acids (FFAs), cholesterol, and TGs and to minimize some of the observed in vitro effects (i.e., apoptosis, ROS generation and lipid accumulation) caused by these fatty acids.
Collapse
|